InsidersTradesSigma
Track the 옵투스제약 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 옵투스제약 has recorded 1 reports. Market capitalisation: €77.8bn. The latest transaction was reported on 10 March 2026 (Other). Among the most active insiders: 옵투스제약. The full history is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 4,793 of 29,065 companies
69.0
score / 100
Value64
Quality74
FCF yld-37%
Earn yld15%
EV/EBITDA5.0x
ROE7.9%
Gross mgn55%
Net mgn13%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 March 2026
关于 옵투스제약
Optus Pharmaceutical 是一家在健康和制药领域运营的公司，在 XKRX 交易所上市。该公司专注于药品的开发和分销。